Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discussion forum response to: High diagnostic yield of family echocardiographic screening of children with bicuspid aortic valve: a critical appraisal and future directions.

European heart journal. Cardiovascular Imaging·2026
Same author

Association of HDL cholesterol, apolipoprotein AI, and E concentrations with foetal growth and placental insufficiency.

Cardiovascular research·2026
Same author

Hyperbaric Oxygen Treatment as a Novel Add-on in Selected Patients with Infective Endocarditis - A Safety and Feasibility Trial.

Infection and drug resistance·2026
Same author

First quinquennium completed: highlights from <i>EHJ Open</i> 2025.

European heart journal open·2026
Same author

Temporal Changes in the Timing of Pulmonary Valve Replacement and Impact on Outcomes in Tetralogy of Fallot.

Pediatric cardiology·2026
Same author

Prosthetic Valve Endocarditis-Insights from the NatIonal Danish Endocarditis stUdieS (NIDUS) Registry.

Diagnostics (Basel, Switzerland)·2026
Same journal

[Mosaicism as a cause of Cowden syndrome].

Ugeskrift for laeger·2026
Same journal

[Thyrotoxic crisis with cardiogenic shock].

Ugeskrift for laeger·2026
Same journal

[Mindfulness-based cognitive therapy in the treatment of depression].

Ugeskrift for laeger·2026
Same journal

[Fitness].

Ugeskrift for laeger·2026
Same journal

[Risk of developing cataract related to fluoroscopy].

Ugeskrift for laeger·2026
Same journal

[Obturator hernia with small bowel ileus presenting as hip pain in an elderly woman].

Ugeskrift for laeger·2026
See all related articles

Related Experiment Video

Updated: Jun 23, 2026

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy
09:57

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy

Published on: September 20, 2024

[Eisenmenger syndrome].

Annette Schophuus Jensen1, Kasper Iversen, Niels G Vejlstrup

  • 1Kardiologisk Klinik B, Rigshospitalet, DK-2100 København Ø. asjensen@dadlnet.dk

Ugeskrift for Laeger
|May 7, 2009
PubMed
Summary
This summary is machine-generated.

Congenital heart disease can lead to Eisenmenger syndrome, causing pulmonary hypertension and cyanosis. This article details precautions to minimize complications and mortality in affected patients.

More Related Videos

Multimodality Diagnosis of Mesenteric Ischemia
05:07

Multimodality Diagnosis of Mesenteric Ischemia

Published on: July 21, 2023

Electrolytic Inferior Vena Cava Model (EIM) of Venous Thrombosis
06:03

Electrolytic Inferior Vena Cava Model (EIM) of Venous Thrombosis

Published on: July 12, 2011

Related Experiment Videos

Last Updated: Jun 23, 2026

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy
09:57

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy

Published on: September 20, 2024

Multimodality Diagnosis of Mesenteric Ischemia
05:07

Multimodality Diagnosis of Mesenteric Ischemia

Published on: July 21, 2023

Electrolytic Inferior Vena Cava Model (EIM) of Venous Thrombosis
06:03

Electrolytic Inferior Vena Cava Model (EIM) of Venous Thrombosis

Published on: July 12, 2011

Area of Science:

  • Cardiology
  • Pulmonary Hypertension
  • Vascular Biology

Context:

  • Congenital heart disease with left-to-right shunt can lead to pulmonary vascular changes.
  • Progressive pulmonary vascular disease can result in Eisenmenger syndrome, characterized by pulmonary arterial hypertension and right-to-left shunting.
  • Eisenmenger syndrome presents significant risks for patients, including acute medical events, surgical complications, and pregnancy-related issues.

Purpose:

  • To outline essential precautions for managing patients with Eisenmenger syndrome.
  • To reduce the morbidity and mortality associated with Eisenmenger syndrome.
  • To provide guidance on the care of individuals with complex congenital heart disease and pulmonary hypertension.

Summary:

  • Left-to-right shunts in congenital heart disease can cause pulmonary vascular proliferation, vasoconstriction, and thrombosis.
  • Eisenmenger syndrome develops due to elevated pulmonary vascular resistance, leading to pulmonary arterial hypertension, right-to-left shunt, and cyanosis.
  • Patients with Eisenmenger syndrome face high risks during medical emergencies, surgery, and pregnancy.

Impact:

  • Implementing recommended precautions can significantly improve patient outcomes.
  • This guidance aims to decrease the incidence of severe complications in Eisenmenger syndrome patients.
  • Enhanced understanding and management strategies are crucial for reducing mortality in this vulnerable population.